Answers are grounded in this paper and cite their sources.
To the Editor: Atopic dermatitis (AD) is a widely prevalent dermatologic condition that can severely impact a patient's quality of life. 1 Individuals with AD have been substantially affected during the COVID-19 pandemic due to the increased use of irritants, decreased access to care, and rise in psychological stress.1,2 These factors have resulted in lower quality of life and worsening dermatologic symptoms for many AD patients over the last few years. 1 One major potential contributory component of these findings is decreased accessibility to in-office care during the pandemic, with a shift to telemedicine instead.Accessibility to care during the COVID-19 pandemic for AD patients compared to those without AD remains unknown.Therefore, we explored the impact of the COVID-19 pandemic on care for patients with AD in a large US population.Using anonymous survey data from the 2021 National Health Interview Survey, 3 we conducted a populationbased, cross-sectional study to evaluate access to care during the COVID-19 pandemic for patients with AD compared to those without AD.We assigned the following 3 survey questions as outcome variables to assess access to care: delayed medical care due to COVID-19 pandemic (yes/no), did not get care due to COVID-19 pandemic (yes/no), and virtual medical appointment in the last 12 months (yes/no).In Table 1, numerous categorical survey variables, including sex, health insurance status, race/ ethnicity, education, US citizenship, birth in the United States, public assistance/welfare, and region, were analyzed using χ 2 testing to evaluate for differences among individuals with and without AD.Multivariable logistic regression models evaluating the relationship between AD and access to care were constructed using Stata/ MP 17 (StataCorp LLC).
No takes yet. Share an insight, caveat, or question.
Brandon Smith (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: